![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
E Grazzini, T Durroux, MD Payet, L Bilodeau, N Gallo-Payet and G Guillon
Centre National de la Recherche Scientifique, Institute National de la Sante et de la Recherche Medicale de Pharmacologie/Endocrinologie U 401, Montpellier, France.
In rat glomerulosa cells, vasopressin stimulates intracellular calcium mobilization via at least two distinct mechanisms: the release of calcium from inositol-1,4,5-P3-sensitive stores and the activation of transmembrane calcium influx. In this study, we focused on the second mechanism through three experimental approaches. By videomicroscopically examining Fura-2-loaded cells, we demonstrate that vasopressin induces a dose-dependent and receptor-mediated calcium influx fully inhibited by either 1 microM nifedipine or a pertussis toxin pretreatment and potentiated by 1 microM BAY K 8644. Patch-clamp experiments also indicate that vasopressin stimulates L-type calcium current by 87% and only weakly inhibits T-type calcium current. To further characterize the coupling between the vasopressin receptor and the dihydropyridine calcium channel, we performed binding studies using tritiated nitrendipine. With this technique, we showed that on intact cells, vasopressin is able to increase the specific binding of tritiated nitrendipine in a dose-dependent manner (Kact = 2 nM). Pharmacological studies using a series of vasopressin analogs revealed that this effect is mediated via a V1a vasopressin receptor subtype. Furthermore, the vasopressin-stimulated nitrendipine binding was sensitive to pertussis toxin pretreatment, which affected only the maximum binding capacity of nitrendipine-binding sites. More interestingly, we demonstrate that vasopressin still increases nitrendipine binding to plasma membrane preparation and that GTP is absolutely necessary for such a hormonal effect. Altogether, these data confirm the existence of a tight and direct coupling between the V1a vasopressin receptor and a dihydropyridine calcium channel via a pertussis toxin-sensitive G protein.
This article has been cited by other articles:
|
|
 |
|
  D. Devost and H. H. Zingg Novel in vitro system for functional assessment of oxytocin action Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E1 - E6. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. SPAT and L. HUNYADY Control of Aldosterone Secretion: A Model for Convergence in Cellular Signaling Pathways Physiol Rev, April 1, 2004; 84(2): 489 - 539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Carraway, S. Hassan, and D. E. Cochrane Polyphenolic Antioxidants Mimic the Effects of 1,4-Dihydropyridines on Neurotensin Receptor Function in PC3 Cells J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 92 - 101. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. A. Dunlap and F. Stormshak Nongenomic Inhibition of Oxytocin Binding by Progesterone in the Ovine Uterus Biol Reprod, January 1, 2004; 70(1): 65 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kostrzewska, B. Modzelewska, and S. Batra Source of calcium for contractile responses of large and small human intramyometrial arteries Hum. Reprod., September 1, 2000; 15(9): 1927 - 1931. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
